Salmonella Typhi IgG/IgM Rapid Test
- UID
- MFG/IVD/2023/000111_6aae35df0a85c99b251529b85d547efc_fa39833fd7e9e70665d3f5eb2650ad00
- Device class
- Class C
- Brand name
- Mediline-SA
- License holder
- S.A-MEDLINE PRIVATE LIMITED
- Approving authority
- CDSCO -North Zone, Ghaziabad
- Product information
- The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (Mediline-SA) IgG and IgM in human serum, plasma or whole blood. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM Rapid Test must be confirmed with alternative testing method(Mediline-SA)
Salmonella Typhi IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000111_6aae35df0a85c99b251529b85d547efc_fa39833fd7e9e70665d3f5eb2650ad00. This device is marketed under the brand name Mediline-SA. The license holder is S.A-MEDLINE PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.